Lipum AB receives 22 MSEK for developing anti-inflammatory drug
After a thorough selection process, Lipum AB has been granted SEK 22 million from the EU’s Horizon 2020-initiative. This is a great leap forward for researchers who want to better quality of life for children and adults with chronic inflammatory diseases.
